A. Yurdakul Et Al. , "Single agent gemcitabine or docetaxel in the second-line therapy for patients with non-small cell lung cancer previously treated with platin-based chemotherapy," EUROPEAN RESPIRATORY JOURNAL , vol.42, 2013
Yurdakul, A. Et Al. 2013. Single agent gemcitabine or docetaxel in the second-line therapy for patients with non-small cell lung cancer previously treated with platin-based chemotherapy. EUROPEAN RESPIRATORY JOURNAL , vol.42 .
Yurdakul, A., Yildirim, F., Baha, A., & ÖZTÜRK, C., (2013). Single agent gemcitabine or docetaxel in the second-line therapy for patients with non-small cell lung cancer previously treated with platin-based chemotherapy. EUROPEAN RESPIRATORY JOURNAL , vol.42.
Yurdakul, Ahmet Et Al. "Single agent gemcitabine or docetaxel in the second-line therapy for patients with non-small cell lung cancer previously treated with platin-based chemotherapy," EUROPEAN RESPIRATORY JOURNAL , vol.42, 2013
Yurdakul, Ahmet Et Al. "Single agent gemcitabine or docetaxel in the second-line therapy for patients with non-small cell lung cancer previously treated with platin-based chemotherapy." EUROPEAN RESPIRATORY JOURNAL , vol.42, 2013
Yurdakul, A. Et Al. (2013) . "Single agent gemcitabine or docetaxel in the second-line therapy for patients with non-small cell lung cancer previously treated with platin-based chemotherapy." EUROPEAN RESPIRATORY JOURNAL , vol.42.
@article{article, author={Ahmet Yurdakul Et Al. }, title={Single agent gemcitabine or docetaxel in the second-line therapy for patients with non-small cell lung cancer previously treated with platin-based chemotherapy}, journal={EUROPEAN RESPIRATORY JOURNAL}, year=2013}